Ventana Global, Inc. (VNTA) Reports Fiscal Year 2025 Results and Publishes Annual Report; Discloses Initial Lending Activity
Denver, Colorado--(Newsfile Corp. - March 27, 2026) - Ventana Global, Inc. (OTCID: VNTA) (the "Company") today announced the publication of its Annual Report for the fiscal year ended December 31, 2025, prepared in accordance with the OTCID Basic Market Alternative Reporting Standard. For the twelve months ending December 31, 2025, the Company reported revenue of $114,577, compared to $41,362 for the year ended December 31, 2024. Net income for 2025 was $86,139, compared to $19,890 in the...
2026-03-27 8:58 AM EDT
Ventana Biotech, Inc. (VNTAD) Announces Name Change to Ventana Global, Inc. and Significant Outstanding Share Reduction
Denver, Colorado--(Newsfile Corp. - January 29, 2025) - Ventana Biotech, Inc. ("Ventana" or the "Company") today announced that it has changed its name to Ventana Global, Inc. (OTC Pink: VNTAD) from Ventana Biotech, Inc. Concurrently with the name change, the Company has significantly reduced its authorized and outstanding shares as the result of a 1 for 20 reverse stock split which was effective January 14, 2025. The name change reflects the Company's evolving strategic focus and its...
2025-01-29 8:05 AM EST